Hossein Borghaei

Title: **Innovations by Hossein Borghaei in Cancer Research**

Introduction

Hossein Borghaei, a prominent inventor based in King of Prussia, PA, is making significant contributions to the field of cancer research. With a focus on innovative therapies, Borghaei holds two patents that showcase his expertise and dedication to advancing medical science.

Latest Patents

Borghaei's latest patents involve groundbreaking antibodies targeting tumor endothelial marker 7R (TEM7R). These antibodies specifically bind to an epitope on the extracellular domain of TEM7R, providing a promising approach for cancer treatment. Along with the antibodies, the patents include nucleic acids encoding these antibodies and cells capable of expressing them. This innovative work suggests applications in methods for treating tumors and inhibiting angiogenesis, which is the formation of new blood vessels that tumors require for growth.

Career Highlights

Currently, Hossein Borghaei is associated with the Institute for Cancer Research, where he utilizes his expertise to drive research aimed at improving cancer therapies. His work is instrumental in developing targeted interventions that can enhance patient outcomes in cancer treatment.

Collaborations

Borghaei collaborates closely with fellow researchers, including Louis M. Weiner, to share knowledge and work towards common goals in the fight against cancer. This collaboration emphasizes the importance of teamwork in advancing medical research and translating findings into effective therapies.

Conclusion

Through his innovative research and patented inventions, Hossein Borghaei is making a valuable impact on the field of cancer research. His work not only paves the way for new treatment options but also highlights the importance of collaboration and innovation in advancing medical science. The advancements stemming from his patents are hopeful steps towards improved therapeutic strategies for managing cancer.